X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (450) 450
Publication (47) 47
Book Review (13) 13
Book Chapter (4) 4
Newsletter (3) 3
Dissertation (2) 2
Web Resource (2) 2
Conference Proceeding (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gemifloxacin (388) 388
humans (193) 193
pharmacology & pharmacy (191) 191
fluoroquinolones (185) 185
microbiology (155) 155
infectious diseases (114) 114
naphthyridines - pharmacology (109) 109
microbial sensitivity tests (108) 108
anti-infective agents - pharmacology (107) 107
ciprofloxacin (84) 84
index medicus (77) 77
levofloxacin (72) 72
moxifloxacin (67) 67
male (61) 61
anti-bacterial agents - pharmacology (60) 60
streptococcus pneumoniae - drug effects (58) 58
quinolones (54) 54
pharmacokinetics (53) 53
streptococcus-pneumoniae (53) 53
susceptibility (49) 49
adult (47) 47
in-vitro (46) 46
female (44) 44
antibiotics (43) 43
fluoroquinolones - pharmacology (41) 41
gemifloxacin mesylate (41) 41
drug resistance, bacterial (40) 40
naphthyridines - pharmacokinetics (40) 40
animals (39) 39
gatifloxacin (39) 39
fluoronaphthyridone (37) 37
fluoroquinolone (37) 37
lb20304 (37) 37
naphthyridines - therapeutic use (36) 36
resistance (36) 36
anti-infective agents - therapeutic use (35) 35
chemistry, analytical (35) 35
middle aged (33) 33
anti-bacterial agents - therapeutic use (32) 32
antimicrobial resistance (32) 32
in-vitro activity (30) 30
ciprofloxacin - pharmacology (28) 28
trovafloxacin (28) 28
anti-infective agents - pharmacokinetics (26) 26
chemistry, multidisciplinary (26) 26
drug resistance, microbial (26) 26
naphthyridines - adverse effects (26) 26
fluoroquinolones - pharmacokinetics (25) 25
pneumonia (25) 25
streptococcus pneumoniae (24) 24
fluoroquinolones - therapeutic use (23) 23
community-acquired pneumonia (22) 22
fluoroquinolone resistance (22) 22
naphthyridines - administration & dosage (22) 22
oncology (22) 22
treatment outcome (22) 22
biochemical research methods (21) 21
efficacy (21) 21
ofloxacin - pharmacology (21) 21
analysis (20) 20
anti-infective agents - adverse effects (20) 20
clarithromycin (20) 20
community-acquired infections - drug therapy (20) 20
anti-bacterial agents - pharmacokinetics (19) 19
pharmacodynamics (19) 19
staphylococcus aureus - drug effects (19) 19
united-states (19) 19
administration, oral (18) 18
aged (18) 18
anti-bacterial agents - administration & dosage (18) 18
antimicrobial activity (18) 18
chemistry (18) 18
drug interactions (18) 18
infections (18) 18
reproducibility of results (18) 18
validation (18) 18
adolescent (17) 17
anti-bacterial agents - adverse effects (17) 17
area under curve (17) 17
bacteria (17) 17
bacterial infections and mycoses (17) 17
biochemical phenomena, metabolism, and nutrition (17) 17
fluoroquinolones - adverse effects (17) 17
internal medicine (17) 17
naphthyridines - chemistry (17) 17
surveillance (17) 17
chromatography (16) 16
dna gyrase (16) 16
double-blind method (16) 16
human plasma (16) 16
methods (16) 16
safety (16) 16
agents (15) 15
anti-infective agents - administration & dosage (15) 15
fluoroquinolones - chemistry (15) 15
gram-positive bacteria - drug effects (15) 15
mutation (15) 15
therapy (15) 15
azithromycin (14) 14
dna gyrase - genetics (14) 14
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (449) 449
Spanish (3) 3
Turkish (3) 3
Chinese (2) 2
Korean (2) 2
French (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 06/2019, Volume 14, Issue 6, p. e0217573
Journal Article
Helicobacter, ISSN 1083-4389, 10/2019, Volume 24, Issue 5, pp. e12628 - n/a
Journal Article
Journal of Radioanalytical and Nuclear Chemistry, ISSN 0236-5731, 4/2011, Volume 288, Issue 1, pp. 307 - 312
Journal Article
South African Journal of Chemical Engineering, ISSN 1026-9185, 12/2017, Volume 24, pp. 8 - 16
The amount of organic micro pollutants like antibiotics detected in effluents, lakes, rivers, hospital wastewater, sewage water and ground water. These... 
Gemifloxacin | Non-biodegradable | Antibiotics | Oxidation technologies | Pharmaceuticals
Journal Article
Ultrasonics Sonochemistry, ISSN 1350-4177, 07/2019, Volume 55, pp. 44 - 56
[Display omitted] •Preparation of ZnO-biochar nanocomposite via facile hydrothermal procedure.•Evaluation of different physicochemical properties of... 
Zinc oxide | Nanocatalyst | Sonocatalysis | Biochar | ZnO-biochar nanocomposite | Ultrasonic Waves | Temperature | Zinc Oxide - chemistry | Nanotubes | Zinc Oxide - toxicity | Gemifloxacin - chemistry | Araceae - drug effects | Catalysis | Charcoal - chemistry | Hydrogen-Ion Concentration
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2014, Volume 59, Issue 8, pp. 1083 - 1091
Background. Ceftriaxone is the foundation of currently recommended gonorrhea treatment. There is an urgent need for backup treatment options for patients with... 
Sexually transmitted diseases | Neisseria gonorrhoeae | Cephalosporins | Antimicrobials | Men | Clinical trials | Infections | Gonorrhea | Preventive medicine | ARTICLES AND COMMENTARIES | School enrollment | Gemifloxacin | Gonorrhea treatment | Gentamicin | Azithromycin | INFECTIOUS DISEASES | CEFTRIAXONE | gemifloxacin | SUSCEPTIBILITY | RESISTANT NEISSERIA-GONORRHOEAE | GONOCOCCAL URETHRITIS | MICROBIOLOGY | azithromycin | IMMUNOLOGY | SEXUALLY-TRANSMITTED INFECTIONS | CEFIXIME | gonorrhea treatment | gentamicin | IN-VITRO ACTIVITY | Gastrointestinal Diseases - epidemiology | Naphthyridines - adverse effects | United States | Humans | Middle Aged | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - adverse effects | Gastrointestinal Diseases - pathology | Adult | Female | Anti-Bacterial Agents - adverse effects | Gentamicins - adverse effects | Gentamicins - therapeutic use | Administration, Oral | Fluoroquinolones - therapeutic use | Treatment Outcome | Injections, Intramuscular | Gonorrhea - drug therapy | Fluoroquinolones - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Azithromycin - adverse effects | Neisseria gonorrhoeae - isolation & purification | Drug Therapy, Combination - methods | Azithromycin - therapeutic use | Naphthyridines - therapeutic use | Adolescent | Gastrointestinal Diseases - chemically induced | Care and treatment | Dosage and administration | Risk factors | and Commentaries
Journal Article
Journal of Saudi Chemical Society, ISSN 1319-6103, 01/2017, Volume 21, Issue S1, pp. S58 - S66
Journal Article
ENVIRONMENTAL ENTOMOLOGY, ISSN 0046-225X, 06/2019, Volume 48, Issue 3, pp. 667 - 673
In recent times, several studies have been undertaken on the artificial mass-rearing of insects in which clinical antibacterial antibiotics, including... 
LIFE-SPAN | glutathione-S-transferase | gemifloxacin | survival | FECUNDITY | BORIC-ACID | ANTIOXIDATIVE RESPONSE | DNA GYRASE INHIBITORS | ENTOMOLOGY | MIDGUT TISSUES | LONGEVITY | METABOLISM | HYDROGEN-PEROXIDE | malondialdehyde | Drosophila melanogaster | LEPIDOPTERA
Journal Article
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, ISSN 1984-8250, 2018, Volume 54, Issue 4
A liquid chromatography method was developed and validated for the determination of gemifloxacin in human plasma using chloramphenicol as internal standard to... 
Gemifloxacin/determination | SB-265805 | Plasma | IN-VITRO | LB20304 | Bioequivalence | PHARMACOLOGY & PHARMACY | SERUM | HPLC
Journal Article
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, ISSN 1386-1425, 12/2015, Volume 151, pp. 360 - 367
Absorbance spectra (1) HP-β-CD, (2) GFX and (3) GFX-HP-β-CD inclusion complex, concentration of GFX 5μg/mL, HP-β-CD 2×10−4M, at room temperature, time 15min,... 
Gemifloxacin | HPβCD | Supramolecular | Molecular modeling | Inclusion complex | SYSTEM | HP beta CD | ASSAY | INCLUSION COMPLEXES | SPECTROPHOTOMETRIC DETERMINATION | ENHANCED SPECTROFLUOROMETRIC DETERMINATION | MESYLATE | SPECTROSCOPY | FORMULATIONS | 18-CROWN-6 | SEPARATION
Journal Article
Journal of Clinical Pharmacy and Therapeutics, ISSN 0269-4727, 02/2018, Volume 43, Issue 1, pp. 134 - 136
Summary What is known and objective Fluoroquinolone‐induced immune‐mediated thrombocytopenia is uncommon, and no reports of cross‐reactivity among... 
drug‐induced immune thrombocytopenia | gemifloxacin | cross‐reactivity | ciprofloxacin | cross-reactivity | drug-induced immune thrombocytopenia | PHARMACOLOGY & PHARMACY | DRUG-INDUCED THROMBOCYTOPENIA | Thrombocytopenia | Ciprofloxacin | Fluoroquinolones | Gemifloxacin | Reactivity | Cross-reactivity
Journal Article
Middle East journal of digestive diseases, ISSN 2008-5230, 04/2017, Volume 9, Issue 2, pp. 100 - 106
BACKGROUND infection is a major casual factor in any peptic diseases. Clarithromycin as one of the drugs recommended for the infection eradication regimen has... 
Gemifloxacin | Clarithromycin | Helicobacter pylori infection | Eradication regimens | Original
Journal Article
Middle East journal of digestive diseases, ISSN 2008-5230, 04/2015, Volume 7, Issue 2, pp. 88 - 93
BACKGROUND Eradication of Helicobacter pylori infection plays a crucial role in the treatment of peptic ulcer. Clarithromycin resistance is a major cause of... 
Gemifloxacin | Clarithromycin | H.pylori | Iran | Original
Journal Article
Asian Journal of Chemistry, ISSN 0970-7077, 10/2009, Volume 21, Issue 8, pp. 6121 - 6129
Journal Article
International Journal of Electrochemical Science, ISSN 1452-3981, 11/2017, Volume 12, Issue 11, pp. 10894 - 10910
Two nanoparticles based potentiometric sensors were fabricated for the selective determination of gemifloxacin mesylate. The first sensor was based on the... 
Gemifloxacin | Carbon paste electrode | Molecularly imprinted | Magnetic nanoparticles | ELECTROCHEMISTRY | ACID | RAT | magnetic nanoparticles | CHROMATOGRAPHY | SENSORS | MS/MS | STABILITY-INDICATING ASSAY | PHARMACEUTICAL FORMULATIONS | PLASMA | carbon paste electrode | molecularly imprinted | ION-SELECTIVE ELECTRODES
Journal Article
Journal of the Formosan Medical Association, ISSN 0929-6646, 01/2020, Volume 119, Issue 1, pp. 367 - 376
Little remains known regarding whether newer FQ with less anti-mycobacterial activity (gemifloxacin) would reduce treatment delay. We identified one... 
Gemifloxacin | Beta-lactam | Treatment delay | Fluoroquinolone | Tuberculosis | MYCOBACTERIUM-TUBERCULOSIS | DIAGNOSIS | COMMUNITY-ACQUIRED PNEUMONIA | RESISTANT | MEDICINE, GENERAL & INTERNAL | NEMONOXACIN | IN-VITRO ACTIVITIES | PULMONARY TUBERCULOSIS | OUTCOMES | EXPOSURE | Drug therapy
Journal Article